ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Cerenome, Inc
2.33
-0.0650
-2.72%
盤後:
2.34
0.0150
+0.65%
19:55 EDT
成交量:
8.00萬
成交額:
19.23萬
市值:
1,764.58萬
市盈率:
-0.53
高:
2.49
開:
2.40
低:
2.31
收:
2.39
52周最高:
23.43
52周最低:
2.31
股本:
758.96萬
流通股本:
645.72萬
量比:
1.29
換手率:
1.24%
股息:
- -
股息率:
- -
每股收益(TTM):
-4.3700
每股收益(LYR):
-7.2500
淨資產收益率:
-614.05%
總資產收益率:
-135.36%
市淨率:
3.23
市盈率(LYR):
-0.32
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Cerenome, Inc
交易所:
NASDAQ
成立時間:
1996
員工人數:
28
公司地址:
6420 Levit Green Blvd,Suite 210,Houston,Texas,United States
官網:
http://www.plustherapeutics.com
郵編:
77021
電話:
210 974 6900
傳真:
210 974 6901
簡介:
Cerenome, Inc.最初於1996年7月成立為加利福尼亞州普通合夥企業,並於1997年5月在特拉華州註冊成立。該公司是一家美國醫療保健公司,致力於開發和商業化用於中樞神經系統(“CNS”)癌症的精確診斷和靶向放射性藥物。CNSide Diagnostics, LLC是其全資子公司,開發和商業化專有實驗室開發的測試,如CNSide,旨在識別癌症和黑色素瘤患者中轉移到中樞神經系統的腫瘤細胞。
董事
名稱
職位
Marc H. Hedrick
President, Chief Executive Officer and Director
Richard J. Hawkins
Chairman of the Board
An van Es Johansson
Director
Howard Clowes
Director
Kyle Guse Esq
Director
Robert Lenk
Director
股東
名稱
職位
Marc H. Hedrick
President, Chief Executive Officer and Director
Andrew Sims
Chief Financial Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/CNSY/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CNSY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","market":"US","secType":"STK","nameCN":"Cerenome, Inc","latestPrice":2.325,"timestamp":1789156800000,"preClose":2.39,"halted":0,"volume":79988,"hourTrading":{"tag":"盘后","latestPrice":2.34,"preClose":2.325,"latestTime":"19:55 EDT","volume":1899,"amount":4449.755,"timestamp":1789170908995,"change":0.015,"changeRate":0.006452,"amplitude":0.012903},"delay":0,"changeRate":-0.02719665271966525,"floatShares":6457200,"shares":7589600,"eps":-4.37005,"marketStatus":"休市中","change":-0.065,"latestTime":"09-11 16:00:00 EDT","open":2.4,"high":2.49,"low":2.31,"amount":192284.992924,"amplitude":0.075314,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.37005,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":2.44,"preClose":2.39,"latestTime":"09:29 EDT","volume":2497,"amount":6057.1996276,"timestamp":1789133370139,"change":0.05,"changeRate":0.020921,"amplitude":0.058326},"postHourTrading":{"tag":"盘后","latestPrice":2.34,"preClose":2.325,"latestTime":"19:55 EDT","volume":1899,"amount":4449.755,"timestamp":1789170908995,"change":0.015,"changeRate":0.006452,"amplitude":0.012903},"volumeRatio":1.2856830537855204},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","floatShares":6457200,"roa":"-135.36%","roe":"-614.05%","lyrEps":-7.25,"volumeRatio":1.2856830537855204,"shares":7589600,"dividePrice":0,"high":2.49,"amplitude":0.075314,"preClose":2.39,"low":2.31,"week52Low":2.31,"pbRate":"3.23","psRate":"4.20","week52High":23.425,"institutionHeld":0.0916,"latestPrice":2.325,"eps":-4.37005,"divideRate":0,"volume":79988,"delay":0,"ttmEps":-4.37005,"open":2.4,"prevYearClose":12.8075,"prevWeekClose":2.755,"prevMonthClose":2.82,"prevQuarterClose":4.37,"fiveDayClose":2.98,"twentyDayClose":3.7,"sixtyDayClose":4.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNSY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"CNSY","fiscalQuarterEnding":"2026/06","expectedEps":-0.96,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-1.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNSY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNSY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1775016000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNSY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNSY","date":"2026-09-11","current":-0.532031,"percent":1,"low":-2.284561,"twenty":-2.209563,"median":-0.887318,"eighty":-0.808178,"high":-0.695308,"avg":-1.305257,"sd":0.647704,"marketCap":18139203},"quantilePoints":[{"date":"2026-08-07","current":-2.22687,"twenty":-2.261485,"median":-2.232639,"eighty":-2.18764,"marketCap":26568789},{"date":"2026-08-14","current":-2.134565,"twenty":-2.237254,"median":-2.212448,"eighty":-2.134565,"marketCap":25467492},{"date":"2026-08-21","current":-0.791526,"twenty":-2.228024,"median":-2.134565,"eighty":-0.843766,"marketCap":20649318},{"date":"2026-08-28","current":-0.901864,"twenty":-2.21764,"median":-1.50083,"eighty":-0.857767,"marketCap":23527837},{"date":"2026-09-04","current":-0.866953,"twenty":-2.210717,"median":-0.8975,"eighty":-0.843766,"marketCap":22617082},{"date":"2026-09-11","current":-0.695308,"twenty":-2.209563,"median":-0.887318,"eighty":-0.808178,"marketCap":18139203}],"updateTime":1789312357505},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":264193,"yearFounded":1996,"employeeNum":28,"address":"6420 Levit Green Blvd,Suite 210,Houston,Texas,United States","zipCode":"77021","officePhone":"210 974 6900","officeFax":"210 974 6901","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.plustherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1561},{"period":"1month","weight":-0.3716},{"period":"3month","weight":-0.5359},{"period":"6month","weight":-0.628},{"period":"1year","weight":-0.8021},{"period":"ytd","weight":-0.8185}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Cerenome, Inc.最初於1996年7月成立為加利福尼亞州普通合夥企業,並於1997年5月在特拉華州註冊成立。該公司是一家美國醫療保健公司,致力於開發和商業化用於中樞神經系統(“CNS”)癌症的精確診斷和靶向放射性藥物。CNSide Diagnostics, LLC是其全資子公司,開發和商業化專有實驗室開發的測試,如CNSide,旨在識別癌症和黑色素瘤患者中轉移到中樞神經系統的腫瘤細胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.059718},{"month":2,"riseRate":0.541667,"avgChangeRate":0.032207},{"month":3,"riseRate":0.375,"avgChangeRate":-0.062118},{"month":4,"riseRate":0.375,"avgChangeRate":-0.005258},{"month":5,"riseRate":0.458333,"avgChangeRate":0.34396},{"month":6,"riseRate":0.24,"avgChangeRate":-0.083556},{"month":7,"riseRate":0.4,"avgChangeRate":-0.008304},{"month":8,"riseRate":0.28,"avgChangeRate":-0.050932},{"month":9,"riseRate":0.52,"avgChangeRate":-0.03592},{"month":10,"riseRate":0.291667,"avgChangeRate":-0.062759},{"month":11,"riseRate":0.375,"avgChangeRate":0.007725},{"month":12,"riseRate":0.375,"avgChangeRate":-0.028095}],"exchange":"NASDAQ","name":"Cerenome, Inc","nameEN":"Cerenome, Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CNSY\",market:\"US\",,,undefined,":{"directors":[{"name":"Marc H. Hedrick","position":"President, Chief Executive Officer and Director"},{"name":"Richard J. Hawkins","position":"Chairman of the Board"},{"name":"An van Es Johansson","position":"Director"},{"name":"Howard Clowes","position":"Director"},{"name":"Kyle Guse Esq","position":"Director"},{"name":"Robert Lenk","position":"Director"}],"executives":[{"name":"Marc H. Hedrick","position":"President, Chief Executive Officer and Director"},{"name":"Andrew Sims","position":"Chief Financial Officer"}]}}}